GMJ

Prof. Giorgi Pkhakadze, MD, MPH, PhD

MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.
Follow:
1634 Articles

Child drowning deaths rising: why doctors urge universal water safety training

Paediatricians and public health officials warn that drowning remains a leading cause of preventable childhood death in the United States,…

Childhood trauma memories remain stable over time, but shift more frequently in children than adults

Research from King's College London published in Nature Mental Health shows that memories of childhood maltreatment remain largely stable over…

European Public Backs State-Funded Fertility Care and Embryo Research, Survey Finds

A Europe-wide survey presented at the European Society of Human Reproduction and Embryology's annual meeting reveals broad public support for…

Influenza surge in Southern Hemisphere prompts PAHO call for vaccination and health system readiness

The Pan American Health Organization has issued an urgent call for increased flu vaccination and strengthened health system preparedness as…

Hormonal Contraceptives With Progestogen Linked to Slightly Elevated Meningioma Risk

A 25-year Danish register study linked progestogen-containing oral contraceptives to a modestly elevated meningioma risk. The Danish Medicines Agency has…

UK Updates Medicine Labelling Standards: New Guidance on Best Practice for Pharmaceutical Packaging

The UK government has published updated guidance on medicine labelling and packaging standards to strengthen patient safety and prevent medication…

Semaglutide Approved for Advanced Liver Disease: First GLP-1 Drug to Treat MASH with Fibrosis

Semaglutide (Wegovy) has become the first glucagon-like peptide-1 receptor agonist approved to treat metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced liver…

Hamilton Medical Updates Safety Instructions for Breathing Circuit Sets After FDA Alert

The FDA has issued a correction notice for Hamilton Medical breathing circuit sets, requiring updated use instructions to prevent obstruction…

© 2026 GMJ News · PHIG · Sheni Network